Host-mediated sugar oxidation promotes post-antibiotic pathogen expansion

Nature

Volumn 534, Issue 7609, 2016, Pages 697-699

  Faber, Franziska ^a   Tran, Lisa ^a   Byndloss, Mariana X ^a   Lopez, Christopher A ^a   Velazquez, Eric M ^a   Kerrinnes, Tobias ^a   Nuccio, Sean Paul ^a   Wangdi, Tamding ^a   Fiehn, Oliver ^b,c   Tsolis, Renée M ^a   Bäumler, Andreas J ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c KING ABDULAZIZ UNIVERSITY   (Saudi Arabia)

Author keywords

[No Author keywords available]

Indexed keywords

CARBOHYDRATE; GALACTARATE; GALACTOSE; GLUCARATE; GLUCOSE; INDUCIBLE NITRIC OXIDE SYNTHASE; REACTIVE NITROGEN SPECIES; STREPTOMYCIN; UNCLASSIFIED DRUG; ANTIINFECTIVE AGENT; GALACTARIC ACID; SACCHARIC ACID; SUGAR ACID;

ANTIBIOTICS; BACTERIUM; DIGESTIVE SYSTEM; GASTROENTERITIS; MICROBIAL COMMUNITY; OXIDATION; PATHOGEN; SUGAR;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIBIOTIC THERAPY; ARTICLE; BACTERIAL PHENOMENA AND FUNCTIONS; CECUM; CECUM MUCOSA; CONTROLLED STUDY; ENZYME ACTIVITY; ESCHERICHIA COLI; FEMALE; GENE CLUSTER; GENE EXPRESSION; MASS FRAGMENTOGRAPHY; MOUSE; NONHUMAN; OPERON; OXIDATION; POST ANTIBIOTIC PATHOGEN EXPANSION; PRIORITY JOURNAL; SALMONELLA ENTERICA SEROVAR TYPHIMURIUM; ANIMAL; CARBOHYDRATE METABOLISM; DRUG EFFECTS; ENZYMOLOGY; GASTROENTERITIS; GENETICS; GROWTH, DEVELOPMENT AND AGING; HOST PATHOGEN INTERACTION; INTESTINE MUCOSA; MALE; METABOLISM; MICROBIOLOGY; OXIDATION REDUCTION REACTION; PATHOGENICITY;

MURINAE; MUS; SALMONELLA ENTERICA;

ANIMALS; ANTI-BACTERIAL AGENTS; CARBOHYDRATE METABOLISM; CECUM; FEMALE; GALACTOSE; GASTROENTERITIS; GLUCARIC ACID; GLUCOSE; HOST-PATHOGEN INTERACTIONS; INTESTINAL MUCOSA; MALE; MICE; NITRIC OXIDE SYNTHASE TYPE II; OPERON; OXIDATION-REDUCTION; REACTIVE NITROGEN SPECIES; SALMONELLA TYPHIMURIUM; STREPTOMYCIN; SUGAR ACIDS;

EID: 84983603118     PISSN: 00280836     EISSN: 14764687     Source Type: Journal    
DOI: 10.1038/nature18597     Document Type: Article

References (30)

1. Pavia, A. T. et al. Epidemiologic evidence that prior antimicrobial exposure decreases resistance to infection by antimicrobial-sensitive Salmonella. J. Infect. Dis. 161, 255-260 (1990).
2. Nelson, J. D., Kusmiesz, H., Jackson, L. H. & Woodman, E. Treatment of Salmonella gastroenteritis with ampicillin, amoxicillin, or placebo. Pediatrics 65, 1125-1130 (1980).
3. Aserkoff, B. & Bennett, J. V. Effect of antibiotic therapy in acute salmonellosis on the fecal excretion of salmonellae. N. Engl. J. Med. 281, 636-640 (1969).
4. Bohnhoff, M., Drake, B. L. & Miller, C. P. Effect of streptomycin on susceptibility of intestinal tract to experimental Salmonella infection. Proc. Soc. Exp. Biol. Med. 86, 132-137 (1954).
5. Nuccio, S. P. & Bäumler, A. J. Comparative analysis of Salmonella genomes identifies a metabolic network for escalating growth in the inflamed gut. MBio 5, e00929-14 (2014).
6. Kelterborn, E. Kauffmann-White-Schema (1989) 1-171 (Bundesgesundheitsamt, 1992).
7. Lamichhane-Khadka, R., Frye, J. G., Porwollik, S., McClelland, M. & Maier, R. J. Hydrogen-stimulated carbon acquisition and conservation in Salmonella enterica serovar Typhimurium. J. Bacteriol. 193, 5824-5832 (2011).
8. Lamichhane-Khadka, R., Benoit, S. L., Maier, S. E. & Maier, R. J. A link between gut community metabolism and pathogenesis: molecular hydrogenstimulated glucarate catabolism aids Salmonella virulence. Open Biol. 3, 130146 (2013).
9. Barthel, M. et al. Pretreatment of mice with streptomycin provides a Salmonella enterica serovar Typhimurium colitis model that allows analysis of both pathogen and host. Infect. Immun. 71, 2839-2858 (2003).
10. Tsolis, R. M., Adams, L. G., Ficht, T. A. & Bäumler, A. J. Contribution of Salmonella typhimurium virulence factors to diarrheal disease in calves. Infect. Immun. 67, 4879-4885 (1999).
11. Ng, K. M. et al. Microbiota-liberated host sugars facilitate post-antibiotic expansion of enteric pathogens. Nature 502, 96-99 (2013).
12. Spees, A. M. et al. Streptomycin-induced inflammation enhances Escherichia coli gut colonization through nitrate respiration. MBio 4, e00430-13 (2013).
13. Stefanovic-Racic, M. et al. Comparison of the nitric oxide synthase inhibitors methylarginine and aminoguanidine as prophylactic and therapeutic agents in rat adjuvant arthritis. J. Rheumatol. 22, 1922-1928 (1995).
14. Palmer, R. M., Ashton, D. S. & Moncada, S. Vascular endothelial cells synthesize nitric oxide from l-arginine. Nature 333, 664-666 (1988).
15. de Souza, M. The use of TEMPO (2, 2, 6, 6-tetramethylpiperidine-N-oxyl) for the oxidation of primary and secondary alcohols. Quim. Nova 27, 287-292 (2004).
16. Sheldon, R. A. & Arends, I. W. C. E. Organocatalytic oxidations mediated by nitroxyl radicals. Adv. Synth. Catal. 346, 1051-1071 (2004).
17. Ozawa, A. & Freter, R. Ecological mechanism controlling growth of Escherichia coli in continuous flow cultures and in the mouse intestine. J. Infect. Dis. 114, 235-242 (1964).
18. Theriot, C. M. et al. Antibiotic-induced shifts in the mouse gut microbiome and metabolome increase susceptibility to Clostridium difficile infection. Nature Commun. 5, 3114 (2014).
19. Hwang, I. et al. Alteration of gut microbiota by vancomycin and bacitracin improves insulin resistance via glucagon-like peptide 1 in diet-induced obesity. FASEB J. 29, 2397-2411 (2015).
20. Tängdén, T. & Giske, C. G. Global dissemination of extensively drug-resistant carbapenemase-producing Enterobacteriaceae: clinical perspectives on detection, treatment and infection control. J. Intern. Med. 277, 501-512 (2015).
21. Lawes, M. & Maloy, S. MudSacI, a transposon with strong selectable and counterselectable markers: use for rapid mapping of chromosomal mutations in Salmonella typhimurium. J. Bacteriol. 177, 1383-1387 (1995).
22. Winter, S. E. et al. Contribution of flagellin pattern recognition to intestinal inflammation during Salmonella enterica serotype Typhimurium infection. Infect. Immun. 77, 1904-1916 (2009).
23. Fiehn, O. et al. Quality control for plant metabolomics: reporting MSI-compliant studies. Plant J. 53, 691-704 (2008).
24. Grozdanov, L. et al. Analysis of the genome structure of the nonpathogenic probiotic Escherichia coli strain Nissle 1917. J. Bacteriol. 186, 5432-5441 (2004).
25. Stojiljkovic, I., Bäumler, A. J. & Heffron, F. Ethanolamine utilization in Salmonella typhimurium: nucleotide sequence, protein expression, and mutational analysis of the cchA cchB eutE eutJ eutG eutH gene cluster. J. Bacteriol. 177, 1357-1366 (1995).
26. Miller, S. I., Kukral, A. M. & Mekalanos, J. J. A two-component regulatory system (phoP phoQ) controls Salmonella typhimurium virulence. Proc. Natl Acad. Sci. USA 86, 5054-5058 (1989).
27. Rivera-Chávez, F. et al. Salmonella uses energy taxis to benefit from intestinal inflammation. PLoS Pathog. 9, e1003267 (2013).
28. Kingsley, R. A. et al. Molecular and phenotypic analysis of the CS54 island of Salmonella enterica serotype Typhimurium: identification of intestinal colonization and persistence determinants. Infect. Immun. 71, 629-640 (2003).
29. Raffatellu, M. et al. Lipocalin-2 resistance confers an advantage to Salmonella enterica serotype Typhimurium for growth and survival in the inflamed intestine. Cell Host Microbe 5, 476-486 (2009).
30. Winter, S. E. et al. Host-derived nitrate boosts growth of E. coli in the inflamed gut. Science 339, 708-711 (2013).